Combino News

News list

Launch of Levofloxacino


July 18, 2008

COMBINO PHARM launches its perfusion solution LEVOFLOXACINO COMBINO PHARM, an anti-infection treatment from the quinolone family, used to treat respiratory, urinary, skin and soft-tissue infections.

LEVOFLOXACINO COMBINO PHARM is designed for use by hospital and infirmary pharmacy services. Vials, which are pre-assembled and ready for use, have a “perfusion handle” to help administer the drug. As with other COMBINO PHARM products, LEVOFLOXACINO COMBINO PHARM vials are bar-coded and supplied with latex-free, anti-coring tops.

LEVOFLOXACINO COMBINO PHARM is sold in clinical packages containing ten 100ml (500mg) vials, with each vial individually packaged to protect the photosensitive active ingredient.

The full name of the product is LEVOFLOXACINO COMBINO PHARM Perfusion Solution and its national drug code is 602937.4. The laboratory price (PVL) is €20.91/unit.

COMBINO PHARM hopes the use of LEVOFLOXACINO COMBINO PHARM will lead to significant savings for hospitals in Spain.